EUVIMEDEUVIMED entdecken
Open Access

Standardized Assessment of Metabolic Bariatric Surgery Outcomes

Ralph Peterli, Saija Hurme, Marco Bueter, Sofia Grönroos, Mika Helmiö, Paulina Salminen

JAMA Surgery · 01.03.2024 · 159 (3) · 306

DOI: 10.1001/jamasurg.2023.6254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Surgery, erschienen am 01.03.2024. Verfasst von Ralph Peterli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research, University of Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Bariatric Surgery, Obesity, Morbid. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance A standardized definition and reporting of metabolic bariatric surgery (MBS) outcomes is not available for actual clinical practice and science.

Objective

To assess the feasibility of using a clinically relevant and feasible MBS outcome score (Swiss-Finnish Bariatric Metabolic Outcome Score [SF-BARI Score]). Design, Setting, and Participants This assessment of a bariatric surgery outcome score is based on the secondary analysis of merged 5-year individual patient data (N = 457) of 2 large randomized clinical trials (Swiss SM-BOSS [Swiss Multicenter Bypass or Sleeve Study], conducted from January 2007 to November 2011, and Finnish SLEEVEPASS [Laparoscopic Gastric Bypass Vs Sleeve Gastrectomy to Treat Morbid Obesity], conducted from March 2008 until June 2010) that compared laparoscopic sleeve gastrectomy with laparoscopic Roux-en-Y gastric bypass in the treatment of severe obesity. This secondary analysis was performed from January 2022 to January 2023. Main Outcomes and Measures The main outcome was the feasibility of the SF-BARI Score and the SF-BARI Score QOL (quality of life) as tools to assess MBS outcomes. The score includes percentage of total weight loss (%TWL), 4 obesity-related comorbidities (type 2 diabetes, hypertension, dyslipidemia, and obstructive sleep apnea), complications, and QOL, if available.

Results

Among the 457 included patients, 323 (70.7%) were female and 134 (29.3%) were male, and the mean (SD) age was 45.6 (10.7) years. Outcomes for the SF-BARI Score were available for 435 patients (95.2%) at 1 year and 398 patients (87.1%) at 5 years and for SF-BARI Score QOL in 289 (63.2%) patients at 1 year and 318 patients (69.6%) at 5 years. The SF-BARI Score was correlated with both the SF-BARI Score QOL ( r = 0.96; 95% CI, 0.95-0.96; P < .001) and %TWL ( r = 0.86; 95% CI, 0.84-0.89; P < .001) and with the Bariatric Analysis and Reporting Outcome System ( r = 0.59; 95% CI, 0.51-0.65; P < .001). Score outcomes were categorized as excellent, very good, good, fair, and suboptimal response. There was a statistically significant difference in scores at 1 vs 5 years (4.0; 95% CI, 1.4-6.6; P = .003), and the gastric bypass group had a higher score compared with the sleeve gastrectomy group (7.4; 95% CI, 3.4-11.5; P < .001). Conclusions and Relevance These findings indicate that this metabolic bariatric surgery outcome score is a simple, relevant, and feasible composite tool to define and measure MBS outcomes, enabling standardized reporting. Trial Registration ClinicalTrials.gov Identifiers: NCT00356213 (SM-BOSS) and NCT00793143 (SLEEVEPASS)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Bariatric SurgeryObesity, MorbidFemaleMaleHumansMiddle AgedQuality of LifeRandomized Controlled Trials as TopicTreatment Outcome

Autor:innen und Institutionen

  • Department of Clinical Research, University of Basel, Basel, Switzerland.
  • Claraunis, Department of Visceral Surgery, University Centre for Gastrointestinal and Liver Diseases, St Clara Hospital and University Hospital Basel, Basel, Switzerland.
  • Department of Biostatistics, University of Turku and Turku University Hospital, Turku, Finland.
  • Department of Surgery, University of Turku, Turku, Finland.
  • Department of Surgery and Transplantation, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Department of Surgery, Männedorf Hospital, Männedorf, Switzerland.

Zitieren

APA

Peterli, R., Hurme, S., Bueter, M., Grönroos, S., Helmiö, M., & Salminen, P. (2024). Standardized Assessment of Metabolic Bariatric Surgery Outcomes. JAMA Surgery, 159(3), 306. https://doi.org/10.1001/jamasurg.2023.6254

Vancouver

Peterli R, Hurme S, Bueter M, Grönroos S, Helmiö M, Salminen P. Standardized Assessment of Metabolic Bariatric Surgery Outcomes. JAMA Surgery. 2024;159(3):306. doi:10.1001/jamasurg.2023.6254

BibTeX
@article{Peterli2024,
  author = {Peterli, Ralph and Hurme, Saija and Bueter, Marco and Grönroos, Sofia and Helmiö, Mika and Salminen, Paulina},
  title = {Standardized Assessment of Metabolic Bariatric Surgery Outcomes},
  journal = {JAMA Surgery},
  year = {2024},
  volume = {159},
  number = {3},
  pages = {306},
  doi = {10.1001/jamasurg.2023.6254}
}
Kostenlos starten →